| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9921 |
| Human Intestinal Absorption | HIA+ | 0.9965 |
| Caco-2 Permeability | Caco2+ | 0.5972 |
| P-glycoprotein Substrate | Non-substrate | 0.8869 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9219 |
| Non-inhibitor | 0.8799 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9273 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6175 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8587 |
| CYP450 2D6 Substrate | Non-substrate | 0.7665 |
| CYP450 3A4 Substrate | Non-substrate | 0.6279 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5890 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9231 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9274 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9548 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9798 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8916 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9833 |
| Non-inhibitor | 0.9587 |
| AMES Toxicity | AMES toxic | 0.7399 |
| Carcinogens | Non-carcinogens | 0.6634 |
| Fish Toxicity | Low FHMT | 0.7741 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.7944 |
| Honey Bee Toxicity | High HBT | 0.7495 |
| Biodegradation | Ready biodegradable | 0.5765 |
| Acute Oral Toxicity | III | 0.7275 |
| Carcinogenicity (Three-class) | Non-required | 0.4866 |